Novartis Pharmaceutical Corporation

40 articles about Novartis Pharmaceutical Corporation

• Off-Label Marketing Puts Novartis AG in Hot Water

  6/20/2013

• Alliance Pharma plc Buys Novartis AG's Syntometrine for $11.5 Million

  6/7/2013

• Novartis AG Says BOLERO-3 Trial Meets Primary Endpoint

  6/3/2013

• Novartis Highlights New Findings in Advancing Care For Patients With 170 Abstracts in Breast, Lung And Blood Cancers at American Society of Clinical Oncology and European Hematology Association

  5/29/2013

• Novartis AG Sees Boost From Program Designed to Speed Life-Saving Therapies

  5/6/2013

• Uncle Sam Busts Novartis AG Again

  4/29/2013

• Incyte Corporation Earns a $25 Million Milestone Payment From Novartis AG

  4/29/2013

• U.S. Accuses Novartis AG of Providing Kickbacks

  4/24/2013

• Novoprotein & Novartis AG Collaboration Reported at the 6th Annual Proteins Congress

  4/17/2013

• Novartis Release: Industry Group Supports Uniform Approach to Transparency of Clinical Trial Data

  4/8/2013

• Clinigen Acquires Oncology Support Therapy Cardioxane® From Novartis AG

  3/26/2013

• Merus Achieves Milestone With Novartis AG Option

  2/7/2013

• European Commission (EC) Charges Johnson & Johnson and Novartis AG With Pay-to-Delay

  1/31/2013

• FDA Gives Nod to Novartis AG's Gleevec for Pediatric ALL

  1/28/2013

• Lincoln Plant Problems Continue to Dog Novartis AG

  1/24/2013

• FDA Approves Novartis AG's Exjade in Patients With Genetic Blood Disorder

  1/24/2013

• Novartis Highlights Key Data on Patients With Hematologic Diseases and Breast Cancer With More Than 140 Abstracts at American Society of Hematology And SABCS

  11/28/2012

• Novartis Warns Jobs May Go Overseas

  11/27/2012

• Genentech Remains Image Leader among Oncologists; Novartis Edges Out Lead among Hematologists

  7/25/2012

• Computers May Predict Drugs Side Effects, University of California, San Francisco (UCSF) and Novartis Study

  6/13/2012